A compilation of the latest news in AI and machine learning

As an integrated health-delivery network comprising 13 hospital campuses, two research centers and a health plan with more than half a million subscribers sitting atop the biggest biobank with whole exome (DNA) sequence data in existence, Pennsylvania’s Geisinger Health System is one of the best-positioned institutions in the U.S. to explore the possibilities and initial successes of AI in healthcare. The institution is bringing complex algorithmic concepts to everyday patient care and showing others the path forward.

Not just for years but for decades, the department of radiology at the University of Wisconsin School of Medicine and Public Health in Madison has been leading the charge on creating innovative technology and translating imaging research into clinical practice.

Countless predictions have been made about artificial intelligence and machine learning changing imaging screening and diagnosis at the point of patient care—and clinical studies and experience are now proving it. Radiologists say the impact is real in improving diagnosis of cancers and quality of care, consistency among readers and reducing read times and unnecessary biopsies. One shining example targets the evaluation of breast ultrasound imaging.

Though healthcare organizations have started to realize AI’s potential, a health coalition led by providers, payers and vendors has made 11 policy recommendations for the technology's role in the space.

Microsoft unveiled a new tool that allows healthcare organizations to create their own AI-powered chatbots and virtual assistants for various services.

As the healthcare industry shifts to providing more personalized care, the precision medical imaging market could see tremendous growth thanks to new technologies, such as AI and deep learning, clinical decision support software, sensors, 3D printing and precision analytics, according to a report from Frost & Sullivan.

IBM is moving forward with a $2 billion expansion in New York to develop a new AI center, according to a report published in The Washington Post.

A recent win by DeepMind, an AI lab owned by Google parent company Alphabet, in a protein-folding problem competition has scientists wondering how the technology can change the drug discovery industry, according to a report by The New York Times.

More than a dozen healthcare AI companies—including Owkin and Arterys—have been named as top startups in CB Insight’s third annual AI 100 list.